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Abstract  
The polysaccharide pectin can be cross linked with calcium ions forming calcium pectinate, a 
material that is ideal for drug release to the colon since it can be degraded by the colonic 
flora.  Particles produced from calcium pectinate can allow an encapsulated drug to be 
released at a controlled rate through the polymers highly ordered and cross linked structure.  
To avoid drug loss before the colonic site is reached, particles can be coated in pH responsive 
polymer coats, facilitating colon targeting.    
In this work, the production of calcium pectinate particles, loaded with 5 aminosalicylic acid 
(5-ASA) was explored.  Their potential for use in controlled drug release to the colon was 
evaluated.  In general, two production methods for the particles were explored; the ‘syringe 
droplet’ method and the ‘water in oil’ emulsion method, where the processing conditions that 
produced high quality particles were investigated.  The characteristics of these particles were 
found to be dependent on the processing parameters selected.  In the syringe droplet method, 
light mixing speeds and high pectin concentrations were essential and in the water in oil 
emulsion method, high emulsifier concentrations with fast mixing speeds were necessary in 
order to produce a satisfactory emulsion.  Loading of 5-ASA into the particles was 
investigated by loading the drug in solution and suspension.  Due to the poor solubility of    
5-ASA in water, encapsulation of the drug in solution resulted in a 0% encapsulation 
efficiency.  Therefore, the 5-ASA was re-encapsulated though a suspension where reasonable 
drug loadings, which were affected by the calcium chloride concentration, were evaluated. 
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However the loaded drug caused a deformity in the structure of the particles.  Particles were 
also subject to in vitro release in conditions simulating the gastrointestinal tract, where the   
5-ASA was rapidly released though all simulations.   This rapid release was believed to be 
due to the incompatibility of the encapsulation of 5-ASA into calcium pectinate particles 
produced by the water in oil emulsion method. The particles were finally subject to 
preliminary coating studies with a pH responsive polymer by a solvent evaporation method 
where it was believed some degree of coating was achieved.  In this method, it was believed 
that an effective polymer coating was produced by sufficient agitation and a satisfactory 
coating solution concentration.    
Acknowledgements 
I am thankful to my supervisor Dr Rachel Bridson, co supervisor Dr Richard Greenwood and 
fellow members of my research group Dr Ian Lee, Mr Matt Barea and Mr John Willett for 
their help and support throughout this project.  
I would like to thank my parents Michael and Coreen McCarry for their help and financial 
support throughout the course.  I would also like to thank my sister Emily McCarry and all 
my friends for their encouragement thought the year.   
 
 
 
 
 
 
 
2 
 
Contents 
 
Chapter 1 - Introduction 
1.0 Background and aims ....................................................................................................... 6 
1.1 Physiology of the human GIT .......................................................................................... 8 
1.1.1 pH variations in the GIT ............................................................................................ 8 
1.1.2 Gastrointestinal micro flora ....................................................................................... 9 
1.2 Controlled release systems for colonic delivery ............................................................ 10 
1.2.1 Slow release matrices .............................................................................................. 10 
1.2.2 pH responsive polymers .......................................................................................... 11 
1.3 Pectin .............................................................................................................................. 12 
1.3.1 Degrees of esterfication and amidation ................................................................... 13 
1.3.2 Pectin applications for colonic delivery .................................................................. 13 
1.3.3 Calcium pectinate .................................................................................................... 14 
1.4 Emulsions ....................................................................................................................... 16 
1.4.1 Types of emulsions .................................................................................................. 16 
1.4.2 Emulsion stabilisation ............................................................................................. 16 
 
Chapter 2 - Syringe droplet method 
2.0 Introduction .................................................................................................................... 18 
2.1 Materials ......................................................................................................................... 18 
2.2 Methods .......................................................................................................................... 18 
2.2.1 Particle production ................................................................................................... 18 
2.2.2 Particle characterisation ........................................................................................... 19 
2.2.3 Swellability .............................................................................................................. 20 
2.3 Results and discussion .................................................................................................... 20 
2.3.1 Effect of pectin concentration on particle formation ............................................... 25 
2.3.2 Effect of calcium chloride concentration on particle formation .............................. 26 
2.3.3 Effect of calcium chloride concentration on swellability ........................................ 26 
2.3.4 Effect of mixing speed ............................................................................................. 28 
2.4 Conclusion ...................................................................................................................... 29 
 
 
3 
 
Chapter 3 - Water in oil emulsion method 
     3.0 Introduction .................................................................................................................... 30 
3.1 Materials ......................................................................................................................... 30 
3.2 Methods .......................................................................................................................... 30 
3.2.1 Original particle production method from the literature ......................................... 30 
3.2.2 Exploring suitability of magnetic mixing on particle formation ............................. 31 
3.2.3 Exploring the effect of cross linking time on particle formation ............................ 31 
3.2.4 Exploring the suitability of overhead mixing on particle formation ....................... 31 
3.2.5 Exploring the effect of emulsifier concentration on emulsion stability .................. 32 
3.2.6 Optimised method for particle production ............................................................... 32 
3.2.7 Particle characterisation ........................................................................................... 33 
3.2.8 Swellability percentage ............................................................................................ 33 
3.3 Results and discussion .................................................................................................... 34 
3.3.1 Exploring the suitability of magnetic mixing on particle formation ....................... 34 
3.3.2 Exploring the effect of cross linking time on particle formation ............................ 35 
3.3.3 Exploring the suitability of overhead mixing on particle formation ....................... 36 
3.3.4 Exploring the suitability of surfactant concentration on particle form .................... 38 
3.3.5 Effect of surfactant concentration on particle formation ......................................... 46 
3.3.6 Effect of mixing speed on particle size and formation ............................................ 47 
3.3.7 Effect of calcium chloride on particle swellability .................................................. 54 
3.4 Conclusion ...................................................................................................................... 55 
 
Chapter 4 - Drug loading and encapsulation of 5-ASA 
4.0 Introduction .................................................................................................................... 57 
4.1 Materials ......................................................................................................................... 57 
4.2 Methods .......................................................................................................................... 57 
4.2.1 Drug loaded particles with 5-ASA solutions ........................................................... 57 
4.2.2 Drug loaded particles with 5-ASA suspensions ...................................................... 58 
4.2.3 Particle characterisation ........................................................................................... 58 
4.2.4 Drug loading and encapsulation efficiency ............................................................. 58 
4.3 Results and discussion .................................................................................................... 60 
4.3.1 Particles prepared with 5-ASA in solution .............................................................. 60 
4.3.2 Particles produced with 5-ASA in suspension ........................................................ 62 
4 
 
4.3.3 Drug loading of 5-ASA loaded in suspension ......................................................... 64 
4.3.4 Encapsulation efficiency.......................................................................................... 65 
4.4 Conclusion ...................................................................................................................... 66 
 
Chapter 5 - In vitro release of 5-ASA from calcium pectinate microspheres 
5.0 Introduction .................................................................................................................... 67 
5.1 Materials ......................................................................................................................... 67 
5.2 Methods .......................................................................................................................... 67 
5.3 Results and discussion .................................................................................................... 70 
5.3.1 Drug release in 0.1M Hydrochloric acid simulating the conditions of the stomach70 
5.3.2 Drug release in Hanks Buffer simulating the conditions of the small intestine ...... 72 
5.3.3 Drug release in PBS simulating the colon ............................................................... 74 
5.4 Conclusion ...................................................................................................................... 77 
 
Chapter 6 - Preliminary investigation into a polymer coating method 
6.0 Introduction .................................................................................................................... 78 
6.1 Materials ......................................................................................................................... 78 
6.2 Methods .......................................................................................................................... 78 
6.3 Results and discussions .................................................................................................. 79 
6.3.1 Effect of mixing speed on Eudragit S100 coating ................................................... 80 
6.3.2 Effect of coating solution concentration .................................................................. 81 
6.4 Conclusion ...................................................................................................................... 82 
 
Chapter 7 - Final conclusions and future work ........................................................................ 83 
7.0 Final conclusions ............................................................................................................ 83 
7.1 Future work .................................................................................................................... 84 
 
   
   
 
 
5 
 
Chapter 1 
Introduction 
1.0 Background and aims 
Over the last two decades, attention has been focused on the colonic region as a site for the 
delivery of some drugs administrated by the oral route (Chen 1998).  The oral route is 
attractive since it is liked by patients encouraging compliance.    Production of oral dosage 
forms can sometimes be cheaper than parental forms since sterile environments may not be 
needed (Chen 1998).  Compared to other regions of the gastrointestinal tract (GIT) the colon 
can be highly responsive to absorption enhancers, offers a less hostile environment for liable 
drugs, and may allow increased bioavailability (Holta 2000).     
However the colon is the last part of the GIT which means obstacles such as change in pH 
and differing enzymes need to be considered where designing an oral dosage form to be 
targeted to the colon.   The acidic pH of the stomach can give rise to some issues.    
Vandamme et al (2001) have discussed that drugs can be prematurely released and degraded 
in the stomach due to its strongly acidic environment.   Also since most absorption and 
digestion occurs in the in small intestine, large volumes of a drug may be lost while travelling 
though this region (Linshu et al 2003).    Many of these disadvantages can be overcome by 
the addition of a pH responsive polymer coat that protects a drug until it reaches the colon.   
The success of colonic delivery systems is therefore dependent on the ability of the 
formulation to protect the incorporated drug from the conditions of the upper GIT.  When 
designing a formulation several factors have to be taken into account;   
• Firstly the drug and its formulation must remain intact from the moment it is taken 
through the mouth and during its journey though the GIT until it reaches the colon, 
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being protected from the harsh acidic environments of the stomach and degradation in 
the small intestine.    
• Secondly the formulation must allow the drug to be released upon entry to the colon. 
• Lastly drug release upon entry to the colon must be predictable and at an appropriate 
rate at the colon site.   
To date, some research has shown that dosage forms composed of polysaccharides can be 
targeted to the colon since they are naturally degraded by the colonic flora (Vandammei et al 
2001), where calcium pectinate has shown much promise (Rubinstein et al 1993).  However, 
particles composed of calcium pectinate can be susceptible to premature release; therefore 
they are often coated with pH responsive polymers, protecting the dosage form en route to the 
colon (Siepmann et al 2008) 
The overall objective of this project was to explore the production of particulate systems 
composed of calcium pectinate that could be used for the oral delivery of drugs to the colon.  
Particularly, emphasis was placed on exploring production methods for the particles then 
evaluating their drug loading and release properties.  More specifically the aims were too;  
• Explore the syringe droplet method for the production of the calcium pectinate 
particles, determining the effect of the key processing parameters on the particle 
characteristics.   
• Explore an alternative production method based on emulsions and again, evaluating 
the effect of the key processing parameters on particle characteristics.   
• Determine whether the particles can be successfully loaded with the model drug, 5-
ASA, a drug used for inflammatory bowel disease.   
• Evaluate the release characteristics of the particles in various in vitro release media 
simulating the stomach, small intestine and colon.   
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• Carry out a preliminary investigation on how to coat the particles in a pH responsive 
coat, which can protect the core en route to the colon.  
1.1 Physiology of the human GIT 
The GIT’s (Figure 1.1) function is to digest food, absorb nutrients and to prevent the 
absorption of harmful substances (Chourasia 2003).  The stomach is the first organ and 
contents can remain here for up to 2 hours (Scheline 1973).  The small intestine is the longest 
section with a high surface area and is therefore where most of the absorbance occurs and 
contents can remain here for around 3 to 6 hours.  The colon is the last organ and contents 
can remain here from 12 to 24 hours (Luishu et al 2003).  These residence times can vary 
from person to person and are also affected by conditions such as diet and age.  
 
Figure 1.1 – The GIT.   The main function is to digest food and protect against harmful substances.  The tracts 
main organs are the stomach, small intestine and colon 
1.1.1 pH variations in the GIT 
Following the route of the GIT from stomach to colon, there is a general increase in the tracks 
pH.  The stomach has a pH of 1.5 to 3.5 which varies depending on whether the stomach is in 
a fasted or fed condition (Luishu et al 2003).  The small intestine has a pH of 5.5 to 6.8.  The 
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colon is made up of the ascending, transverse and descending colon and the pH rises from 7 
in the ascending colon and reaches 7.4 in the descending colon (Luishu et al 2003).  These 
pH values can differ from person to person and are dependent on the age, diet and 
physiological condition of the site (Savage 1977).   
1.1.2 Gastrointestinal micro flora  
Vandamme et al (2001) have discussed that some delivery systems targeted to the colon can 
be triggered by the micro flora that are present in the colonic region. Yang (2000) has 
discussed that the micro flora in the colon survives by fermenting the various types of 
substrates that have been left undigested in the small intestine.   The stomach contains only a 
small number of bacteria and the total number of bacteria increases along the gastrointestinal 
tract. Factors such as the short transit time of material through the stomach and small 
intestine and the low pH of the stomach are most likely responsible for the low bacterial 
content of these organs (Yang 2000). In contrast, the long transit time of the colon, together 
with the high content of nutrients, allows about 400 different bacterial species to thrive in the 
colon (Luishu 2003).   
Studies by Drasar et al (1969) and Semde et al (2000) have seen that many polymers that are 
naturally degraded by these enzymes can be used for colonic drug delivery.  Delivery systems 
produced from these polymers are activated upon entry to the colon.  Most of the recent 
research by Wong et al (2002) and Surajit et al (2010) includes natural polysaccharides being 
applied to create biodegradable colon delivery systems.   The ability of the flora to act as the 
triggering mechanism for a delivery system can vary from person to person.  Factors that 
affect the flora are age, diet and the physiological condition of the site (Safran 1986 and 
Shantha 1995).  
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1.2 Controlled release systems for colonic delivery   
1.2.1 Slow release matrices 
A variety of dosage forms have proven to successfully deliver drugs to the colon at a 
controlled rate.   Such dosage forms include those containing pro drugs, time dependent 
systems and slow release matrices (Singh 2001).   
Slow release matrices have successfully delivered drugs to the colon under a controlled 
release rate by researchers including Wong et al (2002) and Maestrelli et al (2008). The 
method used for the encapsulation is dependent on the chemical characteristics of the drug.  
Wong et al (2002) encapsulated the water soluble sulphanilamide by the water in oil 
emulsion when Maestrelli et al (2008) entrapped the hydrophobic theophylline by the syringe 
droplet method.   Many of these matrices are composed of polymers that are naturally 
degraded by the micro flora in the GIT where polysaccharides such as pectin and chitosan 
have been used.  A variety of production methods have successfully produced particles 
composed of slow release matrices, where common methods are based on emulsions and 
spray drying (Vauthier et al 2008).   
When at the colon site, the colonic fluids will penetrate into the matrices’ and induce 
swelling.  The incorporated drug diffuses out of the particle while the pectin is degraded by 
the colonic flora, though pores created by the penetrating colonic fluids.  This rate can be 
controlled by processing the polymer in way that allows a controlled release rate.  This is 
often preformed in many natural polymers by cross linking the polymer chains (with and 
without use of chemical cross linkers) from a random arrangement into an ordered 
arrangement, producing a denser structure allowing controlled release to be achieved 
(Chourasia et al 2003).      A variety of synthetic and natural polymers can be used for slow 
release matrices.  Ideally they should have low toxicities, give no inflammatory effects or 
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have any harmful by products.  Also their mechanical features should be well suited for the 
indented application (Lakshmi et al 2007).   
1.2.2 pH responsive polymers  
Many matrice blends used for colonic delivery would instantly swell and release the 
incorporated drug in the upper GIT leaving virtually nothing by the time the system enters the 
colon.  This problem can be overcome by coating the matrice with a polymer that dissolves 
when it enters a particular pH environment.  These “smart” polymers that respond to the pH 
changes along the GIT can be used to trigger the drug release.  Polymers are chosen by the 
pH at which they will begin to dissolve so they can target the core matrix to the right part of 
the body.  Table 1.1 shows some common polymers used and their pH solubility thresholds 
(Siepmann et al 2007).  Poly (methacrylates) known as Eudragits have been extensively used 
in colonic delivery.  Eudragits with a pH solubility of pH 7 are ideal where Eudragit S100 has 
been extensively used.   
Table 1.1 – pH solubility threshold of some common pH responsive polymers 
 Polymer pH Solubility 
Eudragit L 100 5.6 
Eudragit S 100 7 
Eudragit L 30D 5.5 
 
Polymers with a threshold of pH 7 are ideal for colonic delivery since they will be resistant to 
the conditions of the upper gastrointestinal tract and will degrade upon entry to the colon 
allowing the full dose to be delivered at the colon site (Figure 1.2).   
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Figure 1.2 – Slow release matrice coated in a pH responsive polymer.  The outer eudragit coating protects 
against the conditions of the lower GIT.  Upon entry to the colon, the eudragit degrades, allowing the drug to 
diffuse though the inner matrice core.   
1.3 Pectin 
Pectin (Figure 1.3) is a polysaccharide that is obtained from the walls of some plants such as 
citrus fruit and apples.  It is a fairly hydrophilic polymer that forms a gel in aqueous media 
(Luishu et al 2003) which has made it an idea polymer for drug delivery applications.  Its 
various chemical characteristics are suited for a range of applications in colonic delivery.
 
Figure 1.3 –Pectin
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1.3.1 Degrees of esterfication and amidation 
Pectin’s characteristics are dependent on the number of carbonyl groups that are present in 
the molecule.  Pectin is classed as having either a high degree of esterfication (DE) or a low 
DE expressed as a percentage.  DEs below 50% esterfication are classed as low DE and those 
greater than 50% are high DE (Luishu et al 2003).   Some of the carbonyl groups when in the 
presence of ammonia can be converted into amide groups producing amidated pectin.  These 
types of pectin groups are known as having degrees of amidation (DA) expressed as a 
percentage.  Both DE and DA determine the number of carbonyl groups in various pectin 
types, when low DE pectin and amidated pectin have more carbonyl groups than high DE 
pectin.  This is an important characteristic to know since pectin with various DEs will be 
better suited for a given application in colonic delivery, where if the wrong type is used, it 
could have a significant impact on the performance of the delivery vehicle.   For example 
high DE pectin is ideal to use in polymer coatings for a core drug since they are less water 
permeable and can be blended with other polymers (Sajeev et al 2009).  Low DE pectin is 
ideal for slow release matrices since more carbonyl groups are present and can be cross 
linked with divalent ions to create the slow release matrices’ mesh like structure (Wong et al 
2002).  
1.3.2 Pectin applications for colonic delivery 
A range of particulate systems, produced from pectin, have shown great promise for colonic 
delivery.  Slow release matrices have shown their potential in a variety of forms.  
Microspheres of high DE pectin were produced showing a sustained release of 5-Fluorouracil 
to the colon, where the pectin particles were coated with a Eudragit S100 coating, protecting 
the drug from premature release until the colon was reached (Paharia et al 2007).  Also high 
DE pectin is often used as a coating to protect an inner drug core since it is less permeable 
making it ideal for controlled release coatings.  Mcloed et al 1997 discussed that the pectin 
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coating could be enhanced, manipulating the coating’s permeability using blends of pectin 
with other polymers such as ethyl cellulose and hydroxypropylmethyl cellulose for the 
coating application, where various release patterns could be achieved by altering the ratio of 
the polymer and pectin.  Pectin systems have also been enhanced by cross linking the pectin 
chains with divalent ions, where calcium ions have been extensively used, to form calcium 
pectinate.   
1.3.3 Calcium pectinate 
Calcium pectinate is an attractive material for colonic delivery since its cross linked structure 
can encapsulate drug molecules allowing a sustained release to be achieved while still leaving 
the pectin liable to enzymatic degradation (Ashford et al 2004). This however is dependent 
on factors such as diet, age and can vary from person to person.    Strong ionic bonds between 
the pectin’s carbonyl groups and the Ca2+ ions are formed.  This causes the pectin chains to 
form highly ordered mesh like structures though arrangements known as the “egg box” 
structure (Figure 1.4).    This procedure is known as ionotropic gelation (Maestrelli et al 
2008) where pectin and other polysaccharides have been frequently used.  The strength of the 
calcium chloride used to cross link the pectin and the number of carbonyl groups in the pectin 
influences the permeability of the material and the release kinetics of an incorporated drug 
(Maestrelli et al 2008).    The permeability of the pectin is highly reduced since the cross 
linked structure increases the pectin’s density, due to the increase in order of the polymer 
chains.   This in turn, reduces the rate which the colonic fluids penetrate into particle 
produced of calcium pectinate, allowing a controlled release of a drug to be achieved (Morris 
1982 and Powell 1982).   
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 Figure 1.4 – Diagram of the egg box model.  The random polymer chains in pectin which are crosslinked into 
more orderly packed structures forming an egg box like model. 
Wong et al (2002) entrapped drugs of various physiochemical characteristics into low DE 
pectin microspheres cross linked with calcium ions producing calcium pectinate 
microspheres, capable of sustained release.  These microspheres were coated with pH 
responsive polymers protecting the cores along the upper GIT, allowing the full dose to be 
release at a controlled rate.  Maestrelli et al (2007), Surajit et al (2009) and Sriamornsak 
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(2008) also entrapped a range of drugs into larger calcium pectinate gel beads displaying a 
sustained release in systems simulating the colon.  Production times for this method are as 
little as 20 minutes and hardening of the gel beads can be promoted by the addition of 
hardening agents such as polyethyleneimine (PEI) (Surajit et al 2006).  Calcium pectinate has 
also shown its potential as a protective coating, where inner drug cores are coated in calcium 
pectinate by the compression coating method (Ashford et al 1993).   
1.4 Emulsions 
Emulsions are systems composed of a continuous phase, a dispersed phase and a stabiliser 
and are a common method for producing particles in drug delivery (Vauthier et al 2009).  
When two immiscible liquids are mixed, one phase (the dispersed phase) is distributed 
throughout the continuous phase in the form of small droplets which are thermodynamically 
unstable.  A variety of types exist depending on the materials and the production process.  
1.4.1 Types of emulsions  
There are a variety of emulsions types.  When an aqueous phase is dispersed into an oily 
continuous phase this is known as water in oil (w/o) emulsion.  Likewise when an oily phase 
is dispersed into an aqueous continuous phase this is known as an oil in water emulsion 
(o/w).  More complex emulsions know as multiple emulsions exist where oil droplets will 
contain smaller water droplets while being dispersed in a continuous aqueous phase, this is 
known as a water in oil in water (o/w/o) emulsion and likewise water in oil in water (w/o/w) 
emulsions exist.  
1.4.2 Emulsion stabilisation  
A variety of theories have been discussed to explain how stabilised emulsions are formed.  
One common theory is the surface tension theory (Billany 2002).  When two immiscible 
liquids are mixed together one phase forms small droplets.  The droplets have internal forces 
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that promote distortion of the droplets shape.  Droplets can be attracted by van der Waals 
forces, when approaching they coalesce forming bigger droplets with a decrease in their 
internal force (Billany 2002).  Addition of surfactants or wetting agents stabilise the emulsion 
system allowing the droplets to remain uniformly distributed in the continuous phase by 
adding an interfacial film which is absorbed into the surface of the droplets lowering their 
internal force preventing particle coalescence (Billany 2002).   
Another theory is where the surfactant places itself around the droplets in a protective film at 
the interface of the oil and water.  This film prevents particle coalescence where the tougher 
the film, the more stabilised emulsion is achieved (Billany 2002).  Enough of a surfactant has 
to be introduced into the emulsion in order to keep the droplets uniformly dispersed 
throughout the continuous phase.   
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Chapter 2 
Syringe droplet method 
 
2.0 Introduction  
The syringe droplet method was investigated for the production of calcium pectinate 
particles.  The processing parameters of pectin concentration and mixer speed were 
investigated and their effects on particle shape were evaluated.   The effects of calcium 
chloride concentration and cross linking time on particle swellability were also explored.     
2.1 Materials   
Pectin with a low degree of esterfication (<50%) was supplied as a gift sample by S Black 
Ltd, Herts, UK.  Calcium chloride dihydrate was supplied by Fisher Scientific, Leicestershire, 
UK.   Double distilled water was used to produce the pectin and calcium chloride solutions.   
2.2 Methods 
2.2.1 Particle production   
The syringe droplet method (Figure 2.1) investigated by Maestrelli et al (2007), Surajit et al 
(2009) and Sriamornsak (1998) was used to produce calcium pectinate particles.   
Pectin solutions were produced by adding 1.5 g and 2.5 g of pectin in its powder form to a 
100 mL beaker and made up to 50 mL with double distilled water, producing two separate 
solutions of 3% w/v and 5% w/v respectively.   The mixtures were stirred at 500 rpm over 
night using a magnetic mixer (Fisher Scientific FB15001) and magnetic flea with a diameter 
of 2.5 cm to ensure complete dissolution of the pectin.   
Calcium chloride solutions were produced by adding 20 g, 40 g and 60 g of calcium chloride 
dihydrate in its solid form into beakers and making up to 200 mL with double distilled water 
and mixed with a 3.5 cm mixing flea producing three separate solutions of 10% w/v, 20% 
w/v and 30% w/v.   
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10 mL of the pectin solution was added drop wise though a 10 mL syringe fitted with an 21G 
needle under magnetic mixing at speeds of 500, 1000 and 1500 rpm into the 250 mL beaker 
containing 200 mL of calcium chloride solution.   
Particles were produced instantly by ionotropic gelation and left to mix for 15 minutes.  The 
mixture was removed from the magnetic mixer and left to cross link.    Cross linking times of 
20, 45, 90 and 180 minutes were investigated.   
The particles were then collected by suction filtration on 1.2 µm filter paper (Fisher 
Scientific) and washed with 200 mL of double distilled water.   
Particles were then left to dry overnight in a petri dish stored in an air circulated oven at 
37 ºC.  Particles were dated, labelled and then stored in an air tight sample vial for further 
studies.   
 
 
 
 
 
 
 
 
 
CaCl2 Ca Pectinate 
beads 
Magnetic 
Mixer 
Syringe containing 
pectin solution 
fitted with a 21 G 
needle 
Figure 2.1 – Apparatus used for production of calcium pectinate particles produced by the syringe droplet 
method.   
 
2.2.2 Particle characterisation  
The dry particles’ form and shape characteristics were characterised by scanning election 
microscopy (SEM) (JEOL 6060).  Three beads were placed on a double adhesive disc stuck 
to a metal SEM stub.  The beads were coated using a gold coater to protect the beads from the 
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election beam.  Hydrated particles were analysed with a light microscope fitted with a digital 
camera (Olympus BH2).  Three particles were placed on a viewing slide and several drops of 
water were added to hydrate the particles and they were analysed using a magnification of 
× 10.    
2.2.3 Swellability  
The particle swellability, expressed as a percentage was investigated as described by Dashora 
et al (2009) and Maestrelli et al (2007).  1 g of dry particles were left to swell in 50 mL of 
double distilled water for 3 minutes.  The particles were collected, weighed (4 decimal 
places) and the swelling percentage was found by the following; 
                                            S = (W1 – Wi) / Wi × 100                                 (2.1) 
Where S is the swell percentage, Wi is the initial weight of particles and W1 the hydrated 
weight of the particles.  The swelling percentage was found using independent triplicate 
batches and a mean value was determined. 
2.3 Results and discussion 
The SEM images of the particles produced with 3% w/v and the 5% w/v pectin solutions are 
shown in Figures 2.2a and 2.2b respectively and the light microscopy images of the particles 
are shown in Figures 2.3a and 2.3b.  Each of the figures shows the effects of the various 
calcium chloride strengths and mixing speeds that were investigated.   
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Figure 2.2a – SEM images of dry pectin particles produced from the 3% w/v pectin solution.  The effects of the 
calcium chloride concentration (10% left, 20% middle and 30% right) and mixing speed (500 rpm top, 1000 rpm 
centre and 1500 rpm bottom) on the particle shape characteristics can be seen. 
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Figure 2.2b – SEM images of dry pectin particles produced from the 5% w/v pectin solution.  The effects of the 
calcium chloride concentration (10% left, 20% middle and 30% right) and mixing speed (500 rpm top, 1000 rpm 
centre and 1500 rpm bottom) on particle shape characteristics can been seen.   
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Figure 2.3a – Light microscopy images of hydrated pectin particles produced from the 3% w/v pectin solution.  
The effects of the calcium chloride concentration (10% left, 20% middle and 30% right) and mixing speed (500 
rpm top, 1000 rpm centre and 1500 rpm bottom) on particle shape characteristics can be seen. 
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Figure 2.3b – Light microscopy images of hydrated pectin particles produced from the 5% w/v pectin solution.  
The effects of the calcium chloride concentration (10% left, 20% middle and 30% right) and mixing speed (500 
rpm top, 1000 rpm centre and 1500 rpm bottom) on particle shape characteristics can be seen.   
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2.3.1 Effect of pectin concentration on particle formation 
The concentration of the pectin solution had a distinct effect on the form of the particles that 
were produced.  The particles that were produced with the 3% w/v pectin solution only gave 
spherical particles at stirring speeds of 500 rpm.  Stirring speeds above 500 rpm gave 
irregularly shaped pectin products while the particles produced with the 5% w/v pectin 
solution gave particles with a more defined spherical geometry over the range of investigated 
parameters.      
The 3% w/v pectin solutions had a lower viscosity and density.  Any particles which begin to 
form can be deformed by the shear stresses created during the mixing process.  Particles 
produced with the 5% w/v pectin solutions had a higher viscosity and density and were able 
to keep the spherical geometry when exposed to the stresses of the mixing process.    
Maestrelli et al (2007), Surajit et al (2009) and Sriamornsak (1998) have discussed the effect 
of pectin concentration in the production of calcium pectinate particles however none of the 
authors have used a concentration less than 5% w/v.  Concentrations in their studies varied 
from 5% to 8% w/v and the spherical particles of approximately 1.7mm in diameter were 
produced.   
It is believed that no other author has previously used solutions of 3% w/v in the syringe 
droplet method, it was therefore hypothesised that the cause of the deformation in the 3% 
pectin particles was because the pectin’s carbonyl groups and the calcium ions do not form as 
strong ionic bonds compared to the 5% w/v solutions. This leaves the pectin’s polymer chains 
with lower degrees of order and therefore with lower densities making the particles 
vulnerable to deformation at high mixing speeds.  Maestrelli et al (2007) also noticed that the 
type of pectin can affect particle shape characteristics, where various ranges of low DE pectin 
(20%, 30% and 40%) were investigated.   
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2.3.2 Effect of calcium chloride concentration on particle formation  
The calcium chloride’s function was to act as the cross linker between the pectin’s carbonyl 
groups and the calcium ions forming the solid particles with the “egg box” structures.  The 
increase in calcium chloride concentration produced particles with higher degrees of 
sphericity when particles were produced with the 5% w/v pectin solution.  However the 3% 
pectin solutions gave distorted particles over the range of calcium chloride concentrations.  
The effect of the calcium chloride on the particles form, which has been discussed by 
Maestrelli et al (2007), was attributed to the efficiency of the ionic bonds produced between 
the pectin carbonyl groups and the calcium ions producing particles with the “egg box” 
structures.  The higher concentrations of calcium chloride were able to produce strong ionic 
bonds resulting in beads with high degrees of sphericity which decreased with the weaker 
calcium chloride concentrations.   
Maestrelli et al (2007) investigated a range of calcium chloride concentrations from 2.5% to 
30% and saw that solutions of 2.5% gave noodle like structures when solutions of 20% gave 
highly spherical beads of approximately 1.7mm in size.   
2.3.3 Effect of calcium chloride concentration on swellability  
The increase in calcium chloride concentration reduced the pectin’s ability to swell as shown 
by the particle swellability percentage (Tables 2.1a and 2.1b).  
By increasing the calcium chloride concentration, the degree of cross linking in the particles 
increases which reduces the amount of water that can penetrate into the particle.  The higher 
degrees of cross linking produced particles with denser structures that reduce the permeability 
of the particle giving the decreasing trend in particle swellability.    
It is ideal to have particles with high degrees of cross linking since this will prevent colonic 
fluids rapidly swelling the pectin particle which would lead to a rapid release rate of an 
incorporated drug.   
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The swellability percentage of the particle provides a numerical value that illustrates the 
swellability for particles produced with different calcium chloride concentrations.    
Maestrelli et al (2007) have discussed the effects of calcium chloride concentration on 
particle swellability.  The increase of calcium chloride concentration promotes the ionic 
bonding leading to denser particles where swelling percentages of 90%, 80% and 70% were 
found for calcium chloride concentrations of 10% 20% and 30% respectively.   
Surajit et al (2006) have shown the effects on cross linking time and their effects on the 
permeability on the pectin microspheres.  Longer periods of time lead to a slightly higher 
degree of cross linking, however the investigated cross linking times in this study had no 
extra effects on the swelling of the particles. 
 
Table 2.1a – Swellability percentages of particles produced with 3% w/v pectin.  The percentage decreases with 
increasing calcium chloride concentration since less water penetrates into the sphere.  The cross link time had no 
effect on the percentage.  Each value represents the mean from three independent studies ± standard deviation. 
 
Calcium Chloride Concentration 
Cross linking  
(mins) 
10% 20% 30% 
0 78 ±1.30 60 ±1.53 40 ±1.56 
20 78 ±1.42 59 ±1.37 39 ±1.33 
45 75 ±1.67 58 ±1.86 37 ±1.21 
90 74 ±1.54 57 ±1.42  37±1.47 
180 73 ±1.29 57 ±1.97 37 ±1.86 
.  
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Table 2.1b – Swellability percentages of particles produced with 5% w/v pectin.  The percentage decreases with 
increasing calcium chloride concentration since less water penetrates into the sphere.  The cross link time had no 
effect on the percentage.  Each value represents the mean from three independent studies ± standard deviation.   
 
Calcium Chloride Concentration 
Cross linking  
(mins) 
10% 20% 30% 
0 81 ±1.43 60 ±1.54 40 ±1.63 
20 78 ±1.76 59 ±1.87 39 ±1.78 
45 77 ±1.53 58 ±1.21 37 ±1.18 
90 76 ±1.64 57 ±1.15 35 ±1.29 
180 75 ±1.38 57 ±1.24  35 ±1.60 
 
2.3.4 Effect of mixing speed 
The increase in mixing speed gave a distortion in the particle’s form due to the increased 
shearing produced in the mixing process.  With the increasing velocity, the flow becomes 
turbulent where the fluid flows in irregular motions producing higher degrees of agitation 
which is believed to deform the particles (Twitchell 2002).  Maestrelli et al (2007), Surajit et 
al (2009) and Sriamornsak (1998) all produced particles operating at “gentle”  mixing speeds 
but do not state a specific speed or the type of mixer used.  It is believed that no other author 
has discussed the effects on mixing speeds above 500 rpm on the formation of the calcium 
pectinate particles produced by the syringe droplet method.   
Since the solid particle forms instantly though ionotropic gelation upon entry into the calcium 
chloride, the size of the particles is completely dependent on the diameter of the needle from 
which the pectin solution is being added drop wise into the calcium chloride solution.  
Various needle sizes were investigated to reduce the droplet size; however, the pectin 
solution was too viscous to squeeze though smaller needles.  Pectin solutions less than 1% 
may be possible; however since pectin concentrations of 5% w/v are needed to obtain 
spherical particles, this low concentration would lead to deformed particles being produced.    
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2.4 Conclusion  
Calcium pectinate particles were produced using the syringe droplet method.   The effects of 
pectin concentration, calcium chloride concentration, cross linking time and mixing speed 
were investigated.  High concentrations of pectin and calcium chloride were ideal to give 
spherical particles and low mixing speeds were needed during the production process to 
avoid the shear stress from deforming the pectin particles though turbulent flow. Spherical 
particles are ideal since they are more elegant.   The Particles would also be likely to undergo 
a coating stage, where spherical particles would be easier to coat.   Cross linking times had no 
effect on the swellability percentage however the swellability was strongly affected by the 
change in calcium chloride concentration. 
In some respects this method is ideal for the production of particles for pharmaceutical use 
since only pectin, calcium chloride and double distilled water are required for their 
production and the method avoided the use of environmentally hazardous chemicals.  Also 
the particles were produced instantly giving short production times which would be more 
economical for larger scales.   
The disadvantages were that the method was limited to the production of relatively large 
particles where alteration of particle size was limited.  Multi particulate systems on the 
micro/nano scale are ideal in colonic delivery since they would be uniformly distributed 
throughout the colon avoiding irregular absorption of a drug.   
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Chapter 3 
Water in oil emulsion method 
 
3.0 Introduction  
A method for the production of the calcium pectinate particles using a water in oil emulsion 
was investigated for producing the particles in the micron size range.  The processing 
parameters of surfactant concentration and mixing speed were investigated showing their 
effects on particle size.   The effect of calcium chloride concentration on particle swellability 
was also explored.   
3.1 Materials 
Pectin of a low DE (< 50%) was obtained as a gift sample from S Black Ltd, Herts, UK.  
Isooctane and calcium chloride where supplied by Fisher Scientific, Leicestershire, UK.   
Span 85 and Tween 85 were supplied by Sigma Aldrich, UK.  Double distilled water was 
used to produce all aqueous solutions.      
3.2 Methods 
3.2.1 Original particle production method from the literature  
The following method was described by Wong et al (2002) and the first to be investigated.   
1.5 g of pectin in a powder form was dissolved in a 100 mL beaker and made up to 50 mL 
with double distilled water and mixed over night on a magnetic mixer (Fisher Scientific 
FB15001)  using a 2.5 cm flea at 500 rpm producing a 50 mL 3% w/v solution.   
This 50 mL solution was added drop wise in five 10 mL portions though a syringe fitted with 
an 18G needle into a 250 mL beaker containing 75 mL of isooctane, which contained 1.75 g 
of Span 85, under continuous mixing at 1000 rpm for 10 minutes.  The 18G needle was 
chosen since it had a small diameter but still allowed the pectin to be dispersed with ease.     
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After the tenth minute 5 mL of an aqueous solution containing 1.8 g of Tween 85 was added 
through another 18G needle and mixed for 5 minutes.   
After the fifth minute 20 mL of calcium chloride solution 30% w/v was added through a third 
18G needle to cross link the pectin particles and mixed for a further 10 minutes.  
The cross linked particles were collected by suction filtration on 1.2 µm filter paper (Fisher 
Scientific) and washed with 200 mL of double distilled water.  The microspheres were then 
dried in an air circulated oven in a petri dish at 37 ºC overnight and stored in air tight sample 
vials.   
The method of Wong et al (2002) was unsuccessful and therefore further method 
development studies were carried out.    
3.2.2 Exploring suitability of magnetic mixing on particle formation 
The method by Wong et al (2002) was performed on a magnetic mixer at mixing speeds of 
1000 rpm.   
3.2.3 Exploring the effect of cross linking time on particle formation 
Before the particles were filtered, they were left to cross link for periods of 20, 45, and 90 
and 180 minutes as investigated by Maestrelli et al (2007) in the syringe droplet method.  
After this cross linking time the particles were collected and dried.   
3.2.4 Exploring the suitability of overhead mixing on particle formation 
The effect of mixer type was investigated by utilising an over head axial flow down pumping 
stirrer with an impeller diameter of 3.5 cm (Fisher Scientific IKARW 20).  The quantities of 
chemicals from the method described by Wong et al (2002) had to be doubled to give a 
sufficient volume to produce particles with this stirrer.  The production times were also 
doubled.   
31 
 
3.2.5 Exploring the effect of emulsifier concentration on emulsion stability 
The Span 85 was increased from 1.7 g to 10 g giving a concentration of 5% w/v.   
3.2.6 Optimised method for particle production 
Particles were produced using an over head mechanical stirrer (Figure 3.1) with some 
modifications to the method described by Wong et al (2002).   
50 mL of the 3% w/v pectin solution was dispersed into a 400 mL beaker with 200 mL of 
isooctane containing 10 g of Span 85 and mixed for 10 minutes at 1000 rpm with an impeller 
with a 3.5 cm diameter.  After this time 10 mL of an aqueous solution containing 2 g of 
Tween 85 was added and mixed for 3 minutes. Then 20 mL of calcium chloride solution was 
added to cross link the pectin and mixed for 5 minutes.   
The emulsions were left for 1.5 hours to cross link after which they were collected by suction 
filtration, washed with 50 mL of double distilled water and dried in an air circulated oven at 
37 ºC overnight in a petri dish.     
Impeller 
Iso octane, 
Span 85 and 
Tween 85 
Pectin droplets 
Syringe containing 3% 
pectin solution fitted 
with an 18G needle  
 
 
 
 
 
 
Figure 3.1 – Apparatus for the water in oil emulsion method for particle production.  The emulsion system 
comprised isooctane as the continuous phase, Span 85 and Tween 85 as the emulsifier and pectin as the 
dispersed phase. 
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3.2.7 Particle characterisation  
The dry particles’ size and shape were characterised by scanning electron microscopy (SEM) 
(JEOL 6060).  A small amount of dry particles were placed onto a double adhesive SEM disc 
stuck to a metal SEM stub.  The particles were coated using a gold SEM coater to protect the 
particles from the electron beam.   
Hydrated Particles were analysed with a light microscope fitted with a digital camera 
(Olympus BH2).  A small mass of particles were placed onto a viewing slide then a few drops 
of water were added to hydrate the particles.  The particles were analysed with × 200 
magnification.     
The average size and size distribution were analysed with laser diffraction particle sizing 
(Mastersizer 2000).  The sizer sample chamber was cleaned with double distilled water and 
particles were added in their dry powdered form into the sample chamber under mixing at 
2000 rpm.  Five readings were recorded for each formulation to calculate the average particle 
diameter along with the size distribution curve.   
The particles were also sized by suspending them in a solution of Tween 85 before sizing.  
100 mg of microspheres were suspended into 5 mL of a 5% w/v Tween 85 solution and 
added into the sample chamber drop wise though a pipette under mixing at 2000 rpm.  Five 
readings were run for each formulation. The average particle diameter along with the size 
distribution curve was obtained.   
3.2.8 Swellability percentage 
The swellability percentage, investigated by Surajit et al (2009), was used to investigate the 
swellability of the particles by finding the mass of water lost from the particles during drying.  
Before the particles were dried during production, 100 mg of the particles were weighed onto 
a petri dish and dried overnight.  The weight of the dry particles was recorded and the 
swellability was found by;    
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                                     S = (Wi – W1) / Wi                                         (3.1)                     
Where S is the swellability, Wi is the initial weight of particles before drying and W1 the 
weight of the dried particles.  
This method was chosen instead of the particle swelling method described in the syringe 
droplet method chapter since it would be difficult to ensure all full mass of spheres were 
recovered after swelling in water due to their small size.   
3.3 Results and discussion 
3.3.1 Exploring the suitability of magnetic mixing on particle formation 
The initial method described by Wong et al (2002) was performed under magnetic mixing to 
produce the calcium pectin particles.   The product was an indiscreet mass of calcium 
pectinate with no particulate products (Figure 3.1).    
 
Figure 3.2 – SEM of the calcium pectinate product produced using the magnetic mixer.  The product obtained 
was an indiscreet mass of polymer with no particulate products.   
 
At this early stage the unsuccessful production attempt producing the indiscreet pectin 
product could have been for a number of reasons.  Firstly the particles could not be receiving 
the sufficient amount of cross linking time in order to form the pectin droplets into solid 
particles.  Also the magnetic mixer could not be giving the necessary shearing forces in order 
to produce spherical droplets.  Lastly, the emulsion could have an insufficient level of 
34 
 
stabilisation in order to keep the droplets form coalescing.  These findings were investigated 
and discussed further in the following sections. 
3.3.2 Exploring the effect of cross linking time on particle formation 
Before the separation process, the emulsions were left on light mixing to allow the particles 
to cross link further.  Cross linking times of 20, 45, 90 and 180 minutes were investigated.  
Cross linking times below 90 minutes were unable to produce spherical particles 
(Figure 3.3a). However cross linking times of 90 and 180 minutes gave some spherical 
products (Figure 3.3b).   
Once dispersed into the isooctane and mixed, the immiscible pectin forms small droplets 
throughout the isooctane.  When the calcium chloride solution is added, the calcium ions 
cross link the pectin chains forming the pectin droplets into solid calcium pectinate particles. 
It is hypothesised that the pectin droplets do not completely cross link in the 10 minute 
mixing period once the calcium chloride is added.  When left for 90 minutes under gentle 
mixing, the additional cross linking time allows the pectin’s carbonyl groups and calcium 
ions to form the strong ionic bonds forming the egg box structures.  This yields the solid 
calcium pectinate products with some spherical geometries.   
Although the products gained had some degree of sphericity, they were not a uniform 
population of individual spheres.   This would not be ideal since they will have to undergo a 
coating process and pharmaceutical products should be uniform in nature.            
Maestrelli et al (2007) have investigated the effects of cross linking time on calcium pectinate 
particles produced with the syringe droplet method.   However it is believed that no other 
author has repeated the effect of this parameter in the context of an emulsion method since 
they claimed that their methods gave spherical products without the additional cross linking 
times.   
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 Figure 3.3a – Effect of cross linking time of the calcium pectinate.  Cross linking times of 20 and 45 minutes 
were not sufficient to give spherical particles.   
 
Figure 3.3b – Effect of cross linking time of the calcium pectinate.  Cross linking times of 90 and 180 minutes 
were sufficient to give the structures required to form solid particles. 
 
3.3.3 Exploring the suitability of overhead mixing on particle formation 
An overhead mechanical stirrer was used to produce the particles giving better agitation and 
prevented the beaker from falling over at higher mixing speeds.   In order to achieve a 
satisfactory emulsion volume to produce the particles the reagent volumes and mixing times 
were doubled.  As the 100 mL of pectin was added, the emulsion became rather thick 
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compared to previous batches and the product obtained was a thick white paste with no 
spherical products (Figure 3.4).   
 
Figure 3.4 – Photograph of the product that was obtained using 100 mL of pectin solution.  The product was a 
creamy paste. 
The pectin was reduced back to the initial 50 mL volume to produce the particles.  Once these 
were collected, the product gained was a population of particles that were in an agglomerate 
form (Figure 3.5).  
 
Figure 3.5 – SEM image of the dried particles.  Spherical products were in an agglomerate form. 
The particles produced with the overhead mixer saw that particulate products were being 
produced due to the increase in agitation.  Magnetic mixing provided a crude method of 
production where it was believed that it did not provide the efficient level of shearing to 
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produce spherical particles. When greater levels of shear are needed, overhead mixers and 
homogenisers can be better suited to the mixing process (Twitchell 2002).  The effect on 
mixer type is a concept that is not often discussed in the literature; however this concept will 
go in to further discussion in a later section.     
3.3.4 Exploring the suitability of surfactant concentration on particle form 
The particles produced were in an agglomerate form which was most likely due to inefficient 
level of stabilisation in the emulsion.  All batches produced so far were done using 1% w/v of 
Span 85 as the stabiliser in the isooctane.  This was increased to 5% w/v.  With this 
emulsifier increase the products gained were a population of spheres with high degrees of 
sphericity (Figure 3.6).  Span 85 was used since it is the ideal emulsifier for water in oil 
emulsions (hlb 1.8) (Wong et al 2002).     
 
Figure 3.6 – SEM showing the effect of increasing the surfactant concentration to 5%.  This gave the emulsions 
the required level of stabilisation in order to give individual spherical particles.   
This increase in surfactant concentration provided the emulsions with the sufficient level of 
stabilisation in order to keep the droplets individually dispersed throughout the isooctane (to 
be discussed in the next section).  It is believed that no other author has discussed the use of a 
surfactant concentration as high as 5% w/v when using water in oil emulsion to prepare 
calcium pectinate microspheres.  
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So far the studies allowed a standardised particle production method to be produced where 
the surfactant concentration and level of agitation had the biggest effects on the formation of 
the pectin particles.  The next stage would be to undergo further investigation into the key 
processing parameters of surfactant concentration, mixing speed and calcium chloride 
concentration.  The parameters investigated were;  
• Surfactant concentration (Span 85) – 1%, 3% and 5% w/v 
• Calcium chloride concentration – 10%, 20% and 30% w/v 
• Mixing speed – 500, 1000 and 1500 rpm 
Particles that were produced were analysed with SEM (Figure 3.7a - c) and light microscopy 
(Figure 3.8a - c).   
   
 
 
 
 
 
 
 
 
 
 
 
 
39 
 
 Span 85 concentration 
 
1% 3% 5%
 
 
 
Figure 3.7 a – Light microscopy images of particles produced with 10% calcium chloride solution showing the 
effect of Span 85 concentrations of 1%, 3% and 5% (left, middle and right) and mixing speeds of 500, 1000 and 
1500 rpm (top, centre and bottom) on the particles’ size and form.   
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Figure 3.7 b – Light microscopy images of particles produced with 20% calcium chloride solution showing the 
effect of Span 85 concentrations of 1%, 3% and 5% (left, middle and right) and mixing speeds of 500, 1000 and 
1500 rpm (top, centre and bottom) on the particles’ size and form.   
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Figure 3.7 c – Light microscopy images of particles produced with 30% calcium chloride solution showing the 
effect of Span 85 concentrations of 1%, 3% and 5% (left, middle and right) and mixing speeds of 500, 1000 and 
1500 rpm (top, centre and bottom) on the particles’ size and form.   
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Figure 3.8 a SEM images of particles produced with 10% calcium chloride solution showing the effect of Span 
85 concentrations of 1%, 3% and 5% (left, middle and right) and mixing speeds of 500, 1000 and 1500 rpm 
(top, centre and bottom) on the particles’ size and form.   
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Figure 3.8 b SEM images of particles produced with 20% calcium chloride solution showing the effect of Span 
85 concentrations of 1%, 3% and 5% (left, middle and right) and mixing speeds of 500, 1000 and 1500 rpm 
(top, centre and bottom) on the particles’ size and form.   
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Figure 3.8 c SEM images of particles produced with 30% calcium chloride solution showing the effect of Span 
85 concentrations of 1%, 3% and 5% (left, middle and right) and mixing speeds of 500, 1000 and 1500 rpm 
(top, centre and bottom) on the particles’ size and form.   
 
 
3.3.5 Effect of surfactant concentration on particle formation  
The concentration of Span 85 used in the emulsions had a distinct effect on the morphology 
of the particles that were produced.  Concentrations of 1% w/v gave indiscreet pectin forms 
with no particulate products.  Concentrations of 3% w/v gave some spherical particles 
however most were distorted in shape.  Concentrations of 5% w/v gave highly defined 
spherical particles where the populations were individually distributed. (Figures 3.7 and 3.8)  
The Span 85 acted as the stabiliser between the pectin droplets and the isooctane enabling the 
droplets to stay uniformly dispersed throughout the emulsion.  When two immiscible liquids 
are mixed the dispersed phase forms small droplets and the system becomes 
thermodynamically unstable (Billany 2002).  The addition of the Span 85 adds a repulsive 
force between pectin droplets and the isooctane phase and avoids the particles from 
approaching each other and coalescing as described by the internal film theory.  Without any 
form of stabilisation the droplets will be attracted by van der Waals forces forming into 
bigger droplets until both liquids return to their individual states.    
Wong et al (2002), Paharia et al (2006) and Esposito et al (2001) have suggested using 0.5% 
- 1.75% w/v of Span 85 in the isooctane and have reported gaining spherical pectin 
microspheres in a size range of 50 to 110 microns in diameter.   These concentrations when 
investigated were unable to stabilise the emulsions leading to a minimum concentration of 
5% w/v being needed to sufficiently stabilise the emulsion.  With these conditions 
microspheres in the size range of 20 microns were formed indicating the increase in 
surfactant concentration could possibly decrease the particle diameter.  Maia et al (2006) 
have discussed that increasing surfactant concentration can give smaller diameter droplets 
since the droplets have a lower internal force and avoid coalescence.   
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It is believed that no other author has discussed the use of Span 85 concentrations above 
1.75% when using a water in oil emulsion for the production of calcium pectinate 
microspheres.  It is believed that the concentrations below 5% were unable to provide films 
that covered the entire surface of the droplets leading to the higher concentrations being used.   
It has been discussed by Maia et al (2006) that the type of pectin used effects the choice of 
surfactant concentration, however these concentrations were still in a range of 0.5 to 1.75% 
w/v.   
3.3.6 Effect of mixing speed on particle size and formation 
The mixing speed of the emulsions affected the size and formation of the microspheres 
produced.  Mixing speeds of 500 rpm gave indiscreet pectin forms.  Once this was increased 
to 1000 rpm some spherical particles were visible, however, the majority of the population 
was in an indiscreet form.  Batches produced at 1500 rpm gave a population of highly defined 
spherical spheres (Figures 3.7 and 3.8).   
The mixing process creates shearing which produces the spherical droplets of a desired size. 
Faster mixing speeds creates smaller droplets likewise with slower mixing speed creating 
larger droplets (Twitchell 2002).  Depending on the materials being mixed, a specific level of 
shearing will be needed in order to create the spherical droplets, where in some cases a 
particular piece of mixing apparatus (overhead mixers/homogenisers for high shear) will need 
to be used (Twitchell 2002).    
Paharia et al (2006) have discussed the effect that these mixing speeds have on the particle’s 
size and from when using a similar over head stirrer.  Increasing the speeds from 500, 1000 
and 1500 rpm produced particles with diameters of 31, 27 and 25 microns respectively 
showing a decreasing particle diameter with increasing mixing speed.  Although the size of 
the pectin product did decrease as shown in the sizing data (Table 3.1), mixing speeds of 
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1500 rpm was the only speed which was able to produce populations of spherical 
microspheres when Paharia et al (2006) claimed the mixing speeds of 500, 1000 and 1500 
rpm all produced populations of spherical spheres.   
It is believed that mixing speeds of 500 rpm did not provide the turbulent flow in order to 
produce spherical microspheres.  One of the mechanisms of liquid mixing is by turbulent 
flow where an impeller in a mixing vessel forces molecules to move in a turbulent manner 
with random changes in the fluid’s motion (Twitchell 2002).  Turbulent flow is necessary in 
the mixing process since it creates the random motions in the fluid flow that gives the high 
degrees of agitation that laminar flow does not provide.   The Reynolds numbers (Re) which 
is a number that identifies if a fluid flow is either laminar or turbulent was found for each 
mixing speed (Table 3.1).   
Table 3.1 – Re numbers for the investigated mixing speeds 
Mixing speed (rpm) Re 
500 14041 
1000 28098 
1500 42140 
 
The Re numbers show that the mixing speeds of 500 rpm gave fluid flow patterns that were 
classed as transitional flow, which is a mixture of laminar and turbulent flow, but not fully 
turbulent.  Turbulent flow (Re > 20000) was required in order to provide the necessary flow 
regime to produce the spherical droplets.  It is believed that this could be the reason that no 
particulate forms were produced at the mixing speed of 500 rpm.  It is believed that in the 
production of calcium pectinate microspheres by the water in oil emulsion method, no other 
author has discussed the concept of flow type on the formation of the particles since it is a 
rarely discussed topic in any pharmaceutical review.     
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The particle sizes and size distributions were analysed with laser diffraction particle sizing.  
Only particles made at 1000 and 1500 rpm were analysed since the formulations produced at 
500 rpm contained no discreet particulate forms.  The size distributions are shown in the 
Figures 3.9 a - f below and particle size statistics are given in Table 3.2  
Table 3.2 – Average particulate size statistics for particles sized in the dry powder form.  Each value 
is the mean for 5 measurements ± standard deviation. 
10% Calcium chloride 20% Calcium Chloride 30% Calcium Chloride 
Particulate 
size statistic 
D10 
(µm) 
D50 
(µm) 
D90 
(µm) 
D10 
(µm) 
D50 
(µm)  
D90 
(µm)  
D10 
(µm) 
D50 
(µm) 
D90 
(µm) 
Sizes at 
1000 rpm 
66 ±4.4 405 ±32  668 ±57 66 ±4.3 418 ±45 924 ±72 46 ±5.9 273 ±22 911 ±78 
Sizes at 
1500 rpm 
26 ±1.8 212 ±21 655 ±48 30 ±1.2 108 ±13 308 ±36 9 ±0.7 46 ±10 115 ±16 
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Figure 3.9a - Size distribution curve for the particles produced at the mixing speed of 1000 rpm with 
10% calcium chloride.   
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Figure 3.9b - Size distribution curve for the particles produced at the mixing speed of 1500 rpm with 
10% calcium chloride.   
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Figure 3.9c - Size distribution curve for the particles produced at the mixing speed of 1000 rpm with 
20% calcium chloride.   
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Figure 3.9d - Size distribution curve for the particles produced at the mixing speed of 1500 rpm with 
20% calcium chloride.   
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Figure 3.9 e - Size distribution curve for the particles produced at the mixing speed of 1000 rpm with 
30% calcium chloride.   
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Figure 3.9f - Size distribution curve for the particles produced at the mixing speed of 1500 rpm with 
30% calcium chloride.   
In general the particle size distributions obtained from laser diffraction particle sizing were 
broad with multiple peaks.  From the SEM images, the sizes of the particles are 
approximately 20 microns in diameter which do not match up to the results obtained from the 
laser sizing.  The particles were added in a dried powder form and while mixing in the sample 
chamber, it was observed that the particles were liable to stick together forming 
agglomerates.  It is believed that it was these agglomerates that were sized rather than the 
individual particles.    
A 5% w/v solution of Tween 85 was used to suspend the particles before analysing in the 
sizer to prevent the agglomerates from forming.  The Tween 85 was chosen since it was used 
in the production of the particles and Span 85 isn’t very soluble in water.   The particles’ size 
distributions are shown in Figures 3.10 a – f and the size statistics in Table 3.3.       
Table 3.3 – Average particulate size statistics for particles sized while suspended in Tween 85.  Each 
value is the mean for 5 measurements ± standard deviation. 
10% Calcium chloride 20% Calcium Chloride 30% Calcium Chloride 
Average 
size 
range 
D10 
(µm) 
D50 
(µm) 
D90 
(µm)  
D10 
(µm) 
D50 
(µm) 
D90  
(µm) 
D10 
(µm) 
D50 
(µm) 
D90 
(µm) 
Sizes at 
1000 rpm 
71 ±13 456 ±34 982 ±73 38 ±1.9 270 ±13 1028 ±97 46 ±1.9 35 ±1.5 911 ±74 
Sizes at 
1500 rpm 
46 ±17 273 ±21  911 ±87 14 ±1.6 32 ±2  71 ±54 11 ±0.4 25 ±0.9 82 ±51 
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Figure 3.10a - Size distribution curve for the particles produced at the mixing speed of 1000 rpm with 
10% calcium chloride.   
 
 Particle Size Distribution  
 0.01  0.1  1  10  100  1000  3000 
Particle Size (µm)
0 
 2 
 4 
 6 
V
ol
um
e 
(%
)
10%ca, 1500RPM, 15 July 2010 11:43:19
10%ca, 1500RPM, 15 July 2010 11:43:48
10%ca, 1500RPM, 15 July 2010 11:44:16
10%ca, 1500RPM, 15 July 2010 11:44:44
10%ca, 1500RPM, 15 July 2010 11:45:13
10%ca, 1500RPM - Average, 15 July 2010 11:43:19
Figure 3.10b - Size distribution curve for the particles produced at the mixing speed of 1500 rpm 
with 10% calcium chloride.   
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Figure 3.10c - Size distribution curve for the particles produced at the mixing speed of 1000 rpm with 
20% calcium chloride.   
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Figure 3.10d - Size distribution curve for the particles produced at the mixing speed of 1500 rpm 
with 20% calcium chloride.  
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Figure 3.10e - Size distribution curve for the particles produced at the mixing speed of 1000 rpm with 
30% calcium chloride.   
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Figure 3.9f - Size distribution curve for the particles produced at the mixing speed of 1500 rpm with 
30% calcium chloride.   
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The size distributions now illustrated some narrower distributions with average particle 
diameters that matched the sizes shown in the SEM images.  Particles produced with 10% 
calcium chloride solutions gave sizes (D50) of 456 and 273 microns at mixing speeds of 1000 
and 1500 rpm respectively.  Batches made with 20% calcium chloride had average size (D50) 
of 270 and 32 microns at mixing speeds of 1000 and 1500 rpm respectively.  Batches 
produced with 30% calcium chloride gave two clear distributions showing an average (D50) 
of 35 and 25 microns at 1000 and 1500 rpm respectively.   
The particles produced with 30% calcium chloride solution with mixing speeds of 1500 rpm 
gave particles that were in a fine powder form which from the SEM images comprises 
individual spheres that are individually distributed.  Particles produced at the other mixing 
speeds and calcium chloride concentrations were in an agglomerate form which is believed to 
have produced the broad distribution data with some multiple peaks and sizing data that 
didn’t match that of the SEM images.   In order to produce an accurate sizing data it was seen 
that the particles had to individually distribute to avoid agglomerates being sized.     The 
process conditions of 10% and 20% calcium chloride and mixing speeds of 1000 rpm gave 
some agglomerate forms which were believed to still being sized giving sizing data that 
differed from the given SEM images.   
3.3.7 Effect of calcium chloride on particle swellability  
The increase in the calcium chloride concentration decreased the permeability of the pectin as 
shown by the swelling percentage (Table 3.3).   
With the increase in calcium chloride concentration the pectin’s density will also increase 
giving spheres with a lower permeability for the same reasons discussed in the previous 
chapter.   The particles swellability percentage was found by measuring the mass of water 
that was lost during drying.  Since the increase in calcium chloride concentration reduces the 
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permeability of the spheres then the spheres produced with higher calcium chloride 
concentrations will have a smaller mass of water being dried from the particle.     
Table 3.4 – Swelling percentage for the range of calcium chloride concentrations.  The increase in calcium 
chloride reduces the amount of water that the sphere can hold giving a reduced swelling percentage.  Each value 
is a mean number from three independent studies ± standard deviation. 
Calcium chloride 
concentration 
Swellability 
percentage 
10% 86% ±2.9 
20% 80% ±3.4 
30% 73% ±2.6 
 
Maestrelli et al (2006) have investigated swelling percentages of   90%, 85% and 79% for 
calcium chloride concentrations of 10%, 20% and 30% respectively.  This trend was found in 
this investigation.  Maestrelli et al (2006) found the percentages by hydrating a known weight 
of dried spheres, blotting with filter paper then re weighing.  This method was not used since 
it was hard to re weigh all the hydrated particles due to their small size therefore a method by 
finding the water loss was used.    Bourgeois et al (2006) has seen that the swelling 
percentage is not only dependent on the efficiency of the ionic bonding between pectin and 
calcium ions but also on the type of pectin used.   
3.4 Conclusion  
This chapter looked into the production of the calcium pectinate microspheres using a water 
in oil emulsion method.  Development of a method in the literature was required before a 
final standardised method was achieved.  Initially a magnetic mixer was used to produce the 
spheres however production was switched to an overhead mechanical mixer providing better 
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agitation.  Also it was seen that particles, once produced, had to be left to undergo additional 
cross linking in order to give defined spherical particles.   
From the range of process parameters that were investigated, it was seen that the success of 
the production of defined spherical particles was dependent on achieving a satisfactory 
stabilised emulsion with span 85 concentrations of  5% (w/v), that were higher than that 
stated in the literature.  Formation of individually distributed spherical particles also required 
a sufficient level of shearing at 1500 rpm to produce the pectin droplets which again the 
literature had not discussed.  Also a calcium chloride concentration of 30% (w/v) was needed 
to give sufficient cross linking to produce the particles in a fine powdered form with a 
reduced permeability.    
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Chapter 4 
Drug loading and encapsulation of 5-ASA 
 
4.0 Introduction 
This chapter describes the addition of the drug 5-amino salicylic acid (5-ASA) into the 
calcium pectinate microparticles.  This drug is used for the treatment of inflammatory bowel 
disease.  The optimised water in oil emulsion method for the production of the calcium 
pectinate particles described in the previous chapter was carried forward for the drug loading 
studies.  These studies were carried out with 5-ASA solutions at concentrations of 0.02 % 
w/v and also with 5-ASA suspensions of 1 %, 2 % and 3 % w/v.   The effects of the calcium 
chloride concentration on the drug loading of the particles were also investigated.       
4.1 Materials    
Pectin of a low DE (<50%) was supplied as a gift sample by S Black Ltd, Herts, UK.  5-ASA, 
Span 85, Tween 85 and pectinase were supplied by Sigma Aldrich, UK.  Isooctane, calcium 
chloride dihydrate, phosphate buffered saline (PBS) were supplied by Fisher Scientific, 
Leicestershire, UK.  Double distilled water was used to produce all aqueous solutions.       
4.2 Methods    
4.2.1 Drug loaded particles with 5-ASA solutions 
The pectin and 5-ASA mixture was produced by dissolving 10 mg of 5-ASA in 20 mL of 
double distilled water.  In a separate beaker 1.5 g of pectin was dissolved in 30 mL of double 
distilled water and mixed for 12 hours.  The 20 mL 5-ASA solution was added under mixing 
to the 30 mL pectin solution.  The final volume of the pectin/5-ASA mixture was 50 mL at 
concentrations of 3% and 0.02% w/v respectively. Particles were then produced using the 
optimised water in oil emulsion method.  Briefly the surfactant concentration was 5% w/v 
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and mixing speed was 1500 rpm along with the various calcium chloride concentrations of 
10%, 20% and 30% w/v.   
4.2.2 Drug loaded particles with 5-ASA suspensions 
1.5 g of pectin was weighed into a 100 mL beaker with 0.5 g, 1 g and 1.5 g of 5-ASA and 
made up to 50 mL with double distilled water forming the suspensions with a pectin 
concentration of  3% w/v and 5-ASA concentrations of 1%, 2% and 3% w/v.   The 
suspensions were then used to produce the particles with the optimised water in oil emulsion 
method.   
4.2.3 Particle characterisation 
The particles’ shape characteristics were analysed by the same methods discussed in the 
previous chapter by scanning electron microscopy (SEM) (JEOL 6060) and light microscopy 
(Olympus BH2).   
4.2.4 Drug loading and encapsulation efficiency 
The drug loaded particles were analysed for their drug content by investigation into the drug 
loading (DL) and encapsulation efficiency (EE).  100 mg of particles were mixed on a 
magnetic mixer in 200 mL of PBS containing 3% w/v pectinase for 12 hours.  Three 1 mL 
samples were removed with a micro pipette and placed into Eppendorf tubes which were 
spun down at 2500 rpm for 5 minutes in a centrifuge.  The supernatant was removed and 
analysed for 5-ASA content by UV spectroscopy (Jasco V-530) at a wavelength of 330 nm 
(Mladenovska et al 2007).   
The drug concentration was determined by comparison to a calibration curve (Figure 4.1) 
which was prepared by serial dilution of a stock solution of 5-ASA with concentrations 
ranging from 0.1 mg/mL to 0.00625 mg/mL.  The stock solution was prepared by dissolving 
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10 mg of 5-ASA in 100 mL of PBS (pH 7.4) producing a solution with a concentration of 0.1 
mg/mL.    
The drug loading in a unit of microspheres is defined as; 
                                    DL = (D/P) x 100                                     (4.1) 
Where DL is the percentage drug loading, D is the mass of drug (mg) released from a unit 
weight of particles and P is the mass of micro particles (mg) used in the drug loading study.   
The encapsulation efficiency was also determined by the ratio of the drug loading found in 
each formulation to the initial drug loading of pectin and 5-ASA used for production.  EE is 
defined as; 
             EE = (D1/Di) x 100                                 (4.2) 
Where EE is the encapsulation efficiency, Di is the initial DL of pectin and 5-ASA used to 
prepare the formulation and D1 is the DL obtained from the produced formulation.     
y = 21.576x
R² = 0.9994
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Figure 4.1 – Calibration Curve of 5-ASA in PBS (pH 7.2).  Three 1 mL samples were assayed by UV 
spectroscopy where a mean value was determined.  Each point is the mean value of three independent studies ± 
standard deviation.   
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4.3 Results and discussion  
 
4.3.1 Particles prepared with 5-ASA in solution 
The ability to load drug in solution into pectin particles was investigated along with the 
effects of calcium chloride concentration on particle morphology, DL and EE.   
These formulations, as expected gave particles where the sphericity of the particle increased 
the increasing calcium chloride concentration (Figures 4.2 and 4.3).   
 
50µm  50µm 50µm
Figure  4.2 – Light microscope images of the  5-ASA drug loaded calcium pectinate particles produced with 
cross linking solutions of 10%  (left), 20%  (middle) and 30% calcium chloride (right). 
 
Figure  4.3 – SEM images of the 5-ASA drug loaded calcium pectinate particles produced with cross linking 
solutions of 10%  (left), 20%  (middle) and 30% (right). 
Although the particles were produced, they were unable to encapsulate the drug (Table 4.1). 
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Table 4.1 – DL of the particles produced with 5-ASA loaded in solution.  The particles were unable to 
encapsulate the drug. 
10% CaCl2 20% CaCl2 30% CaCl2 
DL 0 % 0 % 0 % 
 
Although the quoted solubility of 5-ASA in water at 25 ºC is 1.7mg/mL (Mladenovska et al 
2007) it was found that only 10 mg could be readily dissolved into each 50 mL batch for this 
study. In this emulsion system, a proportion of the drug can be lost to the continuous phase 
(Wong et al 2007).  Since such a small proportion of 5-ASA is used, the drug could also be 
lost to the isooctane phases during the emulsification process (Esposito et al 2001).   
A drugs physicochemical property has a high impact on the DL and EE.  Drugs that are 
highly hydrophilic are known to have much higher DL and EE than drugs that are 
hydrophobic when being encapsulated by water in oil emulsions (Esposito et al 2001).  
Esposito et al (2001) saw that tetracycline, and metronidazol entrapped in pectin particles 
displayed two distinct EE.  Tetracycline, a drug with greater hydrophilic character gave an 
EE of 11.5% compared to metronidazol, having a greater hydrophobic characteristics, gave 
an EE of 0.75%.  
 
To increase the concentration of 5-ASA used to produce the particles by the water in oil 
emulsion, a higher volume of water will have to be included in the pectin/drug mixture which 
could lead to phase inversion of the emulsion, changing the mechanism of the emulsion 
system.  For this reason and given the relatively low solubility of 5-ASA, it is believed that to 
successfully load 5-ASA solutions into pectin particles, it would be necessary to load 
particles produced with another production method.   
Iruıìn et al (2005) used 5-ASA concentrations of 0.5% w/v to produce particles by the syringe 
droplet method preparing calcium alginate particles as opposed to calcium pectinate particles.  
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These particles however were produced using the drug in suspensions.  Mladenovska et al 
(2007) has successfully encapsulated 5-ASA with concentrations of 0.5% w/v into calcium 
alginate particles produced with a spray drying method.  It is believed that no author has 
discussed the encapsulation of 5-ASA into calcium pectinate particles produced with the 
water in oil emulsion method, possibly since the method is not able to produce efficient DL 
since only a small proportion of the drug can be used and is liable to be lost to the isooctane.   
4.3.2 Particles produced with 5-ASA in suspension 
In order to improve drug loading, particles were prepared using the 5-ASA in suspension at 
concentrations of 1 %, 2 % and 3 % w/v.  The resultant particles were irregular in shape with 
needle like formations (Figure 4.4) indicating that the pectin was developing around the 
entrapped 5-ASA’s crystal like structure (Figure 4.5).  The structure of 5-ASA in its dry 
powder form is shown in Figure 4.6.   
Iruıìn et al (2005) used the syringe droplet method to encapsulated 5-ASA at concentrations 
of 0.5% w/v into calcium alginate where the drug was loaded though a suspension.  Their 
particles had diameters of approximately 1.7 mm which is believed to have made them big 
enough to encapsulate the drug without giving the irregular structures that the drug loaded 
though a suspension gave the micron sized particles. 
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Figure 4.4 – Light microscopy images of the drug loaded particles produced with the drug in a suspension.  The 
effects of calcium chloride concentration (10% left, 20% middle and 30% right) and drug concentration (1% 
top, 2% centre and 3% bottom) on the particle form can been seen.  
 
Figure 4.5 – SEM images of the drug loaded particles produced with the drug in a suspension using a drug a 
concentrations of 1% w/v.  The effects of the calcium chloride concentrations (10% left, 20% middle, and 30% 
right) can be seen.     
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 Figure 4.6 –5-ASA in its dry powder form.  It is in a needle like structure.   
4.3.3 Drug loading of 5-ASA loaded in suspension 
The DL of the 100 mg of particles that were analysed for 5-ASA content is shown in Table 
4.2.   
Table 4.2 – DL of the different formulations produced.  Each value is the loading of thee independent studies 
± standard deviation.  
10% CaCl2 20% CaCl2 30% CaCl2 
1%  5-ASA 20% ±2.4 19% ±2.9 17% ±1.8 
2% 5-ASA 36% ±2.7 33% ±2.2  30% ±2.5  
3% 5-ASA 42% ±1.9 39% ±3.2 36% ±2.8 
 
With the increasing drug concentration of 1%, 2% and 3% w/v the DL increased.  With the 
increasing calcium chloride concentration of 10%, 20% and 30% w/v the DL decreased.    
When the number of ionic bonds between the pectin and calcium ions is increased by 
increasing the concentration of calcium chloride, more orderly structures are formed which 
increases the pectin’s density.  This causes the drug to be squeezed out during the production 
process resulting in a lower DL with the increasing calcium chloride concentration (Wakerly 
et al 1997). Surajit et al (2009) investigated the effects of calcium chloride concentrations 
from 0.5% to 5% w/v in a syringe droplet method which saw a decrease in the DL from 25% 
to 18% with the increasing calcium chloride concentration.   
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The size of the particle is also known to affect DL.  Particles with larger diameters have a 
larger volume for a drug to occupy resulting in higher DL.  With the increasing calcium 
chloride concentration from 20% to 30%, the particle size decreases from 35 to 25 microns in 
diameter (as shown in the particle sizing data in the previous chapter) which could also 
contribute to the decreasing DL with increasing calcium chloride concentration.  Yang et al 
(2000) saw that with increasing calcium chloride concentrations of 1%, 2% and 5% w/v the 
size of the particle decreased from 185 to 184 to 174 microns in diameter with DL of 25, 21 
and 18 for the respective particle diameters.   
4.3.4 Encapsulation efficiency 
The encapsulation efficiency (Table 4.3) was obtained using equation 4.2. 
  Table 4.3 – EE of the different formulations produced.  Each is a mean value of three independent studies 
± standard deviation.  
10% CaCl2 20% CaCl2 30 % CaCl2 
1%  5 ASA 80 % ±2.8  76 % ±2.1 68 % ±2.0 
2% 5 ASA 90 % ±2.3 83 % ±2.8 75 % ±2.6 
3% 5 ASA 84 % ±1.7 78 % ±2.5 72 % ±1.8 
 
With the increasing drug concentration from 1% to 2%, the encapsulation efficiency 
increased which then decreased when the drug concentration was increased to 3%.  With the 
increasing calcium chloride concentrations, the encapsulation efficiency decreased.   
The initial increase in EE following a decrease with the increasing 5-ASA concentration is 
most likely due to the increasing drug: polymer ratio reaching a limit were the 5-ASA loaded 
into the pectin reaches a maximum (between 5-ASA concentrations of 2% and 3% w/v). 
Sriamornsak (1998) loaded bovine serum albumin (BSA) into pectin beads produced by the 
syringe droplet method.  5 g, 10 g and 20 g of BSA were loaded giving EE of 60%, 24% and 
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23% where the increasing drug: polymer ratio reached a limit at BSA loadings of 10 g 
resulting in the decreased EE.   
 
As with the drug loading, the encapsulation efficiency decreased with increasing calcium 
chloride concentrations, since the increase in particle density squeezed the drug out during 
the emulsification process.   
Most colonic delivery reviews are based on the syringe droplet method as opposed to the 
water in oil emulsion method.  Maestrelli et al (2007) used the syringe droplet method to 
produce calcium pectinate beads with EE as high as 99 % and DL of 32 %.  It is believed that 
no comparison between the two methods has been discussed in the literature however the 
higher EE compared to the water in oil emulsion method is believed to be due to the short 
production time and instant hardening of the pectin particles.   
4.4 Conclusion  
The drug loaded particles were produced with the optimised water in oil emulsion method by 
loading the 5-ASA while in solution and also in suspension.  The 5-ASA when loaded in a 
solution failed to produce any drug loaded particles.  This was possibly since the solubility of 
the 5-ASA only allowed 10 mg of the drug to be loaded into each batch which was believed 
to be lost to the isooctane during the emulsification process.  The particles produced with the 
drug loading in a suspension gave particles with fairly reasonable drug loadings and 
encapsulations efficiencies; however, these gave the particles irregular structures in line with 
the 5-ASA’s needle like structure.  If 5-ASA were to be used as a drug model in this study, it 
is believed that the syringe droplet method would be more efficient since the drug needs to be 
in suspension in order to produce particles with an effective DL and EE.    
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Chapter 5 
In vitro release of 5-ASA from calcium pectinate microspheres 
 
5.0 Introduction 
The drug loaded particles produced with 2% w/v 5-ASA suspensions were subject to in vitro 
drug release studies in conditions simulating various regions of the GIT.  Hydrochloric acid 
(HCl), Hanks buffer and phosphate buffered saline (PBS) were used to simulate the stomach, 
small intestine and colon respectively.  The effect of the calcium chloride concentration on 
the release rate of the drug was investigated.   
5.1 Materials  
Concentrated HCl, Hanks buffer and PBS tablets were supplied by Fisher Scientific, 
Leicestershire, UK. Double distilled water was used to prepare all aqueous solutions.     
5.2 Methods  
300 mL of each drug release media used for the study were prepared as follows.  HCl (0.1M) 
(pH 1.2) was prepared by diluting 8.33 mL of the concentrated HCl and making up to 1 L 
with double distilled water.  The Hanks buffer (pH 6.4) was ready to use from Fisher 
Scientific.  The PBS (pH 7.2) was prepared by dissolving 3 PBS tablets in 300 mL of double 
distilled water.   
100 mg of drug loaded particles along with 300 mL of drug release media were weighed and 
measured out and placed into a 500 mL conical flask plugged with a foam plug.  The conical 
flasks were placed into a shaking incubator and mixed at 100 rpm at 37 ºC.   
The duration of the drug release study was 2 hours for the stomach, 6 hours for the small 
intestine and 20 hours for the colon. Three 1 mL samples were removed using a micro pipette 
every 30 minutes for 2 hours, then on an hourly basis.  The volumes removed were replaced 
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with fresh media.  The samples were placed into Eppendorf tubes and spun down in a 
centrifuge at 2500 rpm for 5 minutes.  0.75 mL of the supernatant was removed and analysed 
for 5-ASA content with UV spectroscopy at a wavelength of 330 nm (Mladenovska et al 
2007).  All release studies were preformed in triplicate.   
The drug concentration was obtained by comparison to a calibration curve (Figures 5.1 – 5.3) 
of 5-ASA in each drug release media which was produced by the methods discussed in the 
previous chapter.   The cumulative drug release was plotted against time on a separate graph 
for each simulated organ.   
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Figure 5.1 – Calibration curve of 5-ASA in Hydrochloric acid (pH 1.2).  Three 1 mL samples were assayed by 
UV spectroscopy where a mean value was determined.  Each point represents three independent studies ± 
Standard deviation.   
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Figure 5.2 – Calibration curve of 5-ASA in Hanks Buffer (pH 6.4).  Three 1 mL samples were assayed by UV 
spectroscopy where a mean value was determined.  Each point represents three independent studies ± Standard 
deviation.   
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Figure 5.3 – Calibration curve of 5-ASA in PBS (pH 7.2).  Three 1 mL samples were assayed by UV 
spectroscopy where a mean value was determined.  Each point represents three independent studies ± Standard 
deviation.   
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5.3 Results and discussion 
5.3.1 Drug release in 0.1M Hydrochloric acid simulating the conditions of the stomach 
The cumulative drug release profile for particles produced with the various calcium chloride 
concentrations in conditions simulating the stomach is shown in Figure 5.4 along with the 
percentage release in Figure 5.5.   
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Figure 5.4 –Cumulative drug release profile from 100 mg of calcium pectinate microspheres in 300 mL 0.1M 
Hydrochloric acid (pH 1.2).  The effects of the various calcium chloride concentrations of 10%, 20% and 30% 
on the release profile are shown.  Three 1 mL samples were removed and assayed by UV spectroscopy where a 
mean value was determined, each point represents three independent studies ± standard deviation.  
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Figure 5.5 – Percentage drug release from 100 mg of calcium pectinate microspheres in 300 mL 0.1M 
hydrochloric acid (pH 1.2).  The effects of the various calcium chloride concentrations of 10%, 20% and 30% 
on the release profile are shown. Three 1 mL samples were removed and assayed by UV spectroscopy where a 
mean value was determined, each point represents three independent studies ± standard deviation.   
From the release profile the 5-ASA was rapidly released in the first hour.  In acidic 
conditions calcium pectinate avoids degradation but will swell (Luishu et al 2003), however 
in reality the particles would normally be coated, protecting the pectin/drug matrice from the 
stomach conditions.    Interestingly the results from the UV spectroscopy readings indicated 
that the cumulative release in the HCl was greater than was theoretically possible when 
compared to the DL studies in the previous chapter.  For the calcium chloride concentrations 
of 10%, 20% and 30%, 5-ASA masses of 20 mg, 19 mg and 17 mg should have been released 
for the respective concentrations where in this study 5-ASA masses of up to 27 mg were 
being detected by the UV spectroscopy.  
30 minutes into the release study, the particles were recovered and analysed with light 
microscopy (Figure 5.6).  The image shows the pectin particles still intact without the 5-ASA 
crystals where it is believed that the crystals dropped out into the HCl media as the particles 
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swell.  It is also believed that some of the 5-ASA remains in a solid form in the HCl leading 
to the higher than expected absorbance reading.   
 
Figure 5.6 – Light microscope images of the drug loaded particles before the drug release study (left) and 
recovered after the 2 hour release study in HCl (right).  It is believed that the particles swell and the 5-ASA 
drops out in a solid form into the release media rather than diffusing out.   
Although the study was designed to ensure sink conditions at pH 7.4, the solubility of 5-ASA 
(an acid drug) in release media at pH 1.2 will be considerably lower than that at pH 7.4 
(1.7mg/mL; Mladenovska et al 2007), which is believed to have kept some of the drug once it 
dropped out of the particles in its solid form. If this study was to be repeated it would be 
important to take into account the solubility of the drug at different pH levels.   
Previously authors have failed to give a detailed review of drug release in conditions 
simulating the stomach since the particles will remain protected (e.g. by Eudragit coatings) in 
the regions of the lower GIT and their discussions focus on release in colonic conditions.   
5.3.2 Drug release in Hanks Buffer simulating the conditions of the small intestine 
The release profile for particles produced with the various calcium chloride concentrations in 
conditions simulating the small intestine is shown in Figure 5.7 along with the percentage 
release in Figure 5.8.      
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Figure 5.7 – Cumulative drug release profile from 100 mg of calcium pectinate microspheres in 300 mL Hanks 
buffer (pH 6.4).  The effects of the various calcium chloride concentrations of 10%, 20% and 30% on the release 
profile are shown. Three 1 mL samples were removed and assayed by UV spectroscopy where a mean value was 
determined, each point represents three independent studies ± standard deviation.   
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Figure 5.8 – Percentage drug release from 100 mg of calcium pectinate microspheres in 300 mL Hanks buffer 
(pH 6.4).  The effects of the various calcium chloride concentrations of 10%, 20% and 30% on the release 
profile are shown.  Three 1 mL samples were removed and assayed by UV spectroscopy where a mean value 
was determined, each point represents three independent studies ± standard deviation. 
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As with the HCl the drug release in the Hanks buffer gave higher cumulative release than 
expected, which is believed to be due to the same reasons in conditions simulating the 
stomach with undissolved solid 5-ASA crystals giving higher absorbance readings.     
Like with the stomach conditions, reviews fail to give detailed discussions on the conditions 
of the small intestine again since the inner matrix will often be protected with a Eudragit 
coating. It is known in some pectin delivery systems coated in a Eudragit can release about 
4 % of the encapsulated drug before reaching the colon (Paharia et al 2007).  This is believed 
to be due to the increasing pH that can begin to degrade the coating and the release of a small 
percentage of the drug that is on the surface of the particles.   
5.3.3 Drug release in PBS simulating the colon 
The release profile for particles produced with the various calcium chloride concentrations in 
conditions simulating the colon is shown in Figure 5.9 along with the percentage release in 
Figure 5.10.     
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Figure 5.9 – Cumulative drug release profile from 100 mg calcium pectinate microspheres in 300 mL PBS (pH 
7.2).  The effects of the various calcium chloride concentrations of 10%, 20% and 30% on the release rate are 
shown.  Three 1 mL samples were removed and assayed by UV spectroscopy where a mean value was 
determined, each point represents three independent studies ± standard deviation. 
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Figure 5.10 – Percentage drug release from 100 mg calcium pectinate microspheres in 300 mL PBS (pH 7.2).  
The effects of the various calcium chloride concentrations of 10%, 20% and 30% on the release profile are 
shown.  Three 1 mL samples were removed and assayed by UV spectroscopy where a mean value was 
determined, each point represents three independent studies ± standard deviation. 
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From the release profile the drug was rapidly released from each batch of microspheres 
produced with the various calcium chloride strengths, but no change in release rate with the 
varying calcium chloride concentrations could be seen.  The study was performed under sink 
conditions and the mass of drug released into the colonic media matched the theoretical result 
found in the DL of the particles.  With the increasing calcium chloride concentration the total 
mass of drug released from the particles decreased.  This was as expected since the DL 
decreases with increasing calcium chloride as discussed in the previous chapter.
The particles contained the solid 5-ASA crystals.  The particles’ shape adapted to that of the 
5-ASA needle like crystals.  It was believed that this left the crystal non-uniformly distributed 
in the particles where the 5-ASA crystal poked out with thin layers of pectin surrounding 
them (circled in Figure 5.11).  It is believed that when the particles swell in the colonic 
media, as stated in the other release media sections, the drug rapidly drops out due to this 
non-uniform distribution.
Figure 5.11 – Drug loaded particles where the particle shape adapted to the solid 5-ASA needle like structure. 
It is hypothesised that there was not enough space for the solid 5-ASA crystals to occupy in 
the micron sized particles.  As stated in the previous chapter it is believed that the pectin 
particles loaded with 5-ASA on the micron scale have only been achieved by a spray drying 
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method (Mladenovska et al 2007), and more commonly by particles produced on the 
millimetre scale by the syringe droplet method (Iruıìn et al 2005).  
If the drug loaded particles had been produced with the syringe droplet method, it is believed 
that the bigger particles would have had a larger volume for the 5-ASA crystals to occupy 
allowing the drug to be properly encapsulated, and released at a controlled rate.  The drug 
would be released by the colonic fluids penetrating into the particle inducing swelling; the 
drug would diffuse out at a slow rate since it is in a solid form though pores that are created 
by the colonic fluids.  Particles produced with higher calcium chloride concentrations will 
swell at a slower rate resulting in a slower release rate.    
5.4 Conclusion 
The drug loaded particles produced with 2% w/v 5-ASA suspensions were put though in vitro 
studies in conditions simulating the stomach, small intestine and colon.  From the results, the 
5-ASA was rapidly released.  Due to this rapid release a clear comparison on the effects of 
various calcium chloride concentrations on drug release could not be made.  It was 
hypothesised that particles produced on the micron scale by the emulsion method had 
insufficient volumes to allow the 5-ASA to be properly encapsulated and released, resulting 
in solid 5-ASA crystals rapidly precipitating out into the release media.  It is believed that a 
delivery vehicle composed of 5-ASA entrapped in calcium pectinate particles produced on 
the micron scale and showing a controlled release throughout the colon has not been 
discussed in the literature since most production methods are based on the syringe droplet 
method.  For this reason it is believed that the syringe droplet method would have been better 
suited for encapsulation of the 5-ASA suspensions.   
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Chapter 6 
Preliminary investigation into a polymer coating method 
 
6.0 Introduction                                                                                                                                                  
The aim of this study was to attempt to coat the pectin particles.  The polymer chosen for the 
coating was Eudragit S100 since its pH solubility threshold is pH 7.   This would help to 
ensure that the pectin/5-ASA matrix would remain protected until the colon site is reached.  
The conditions that were briefly investigated were Eudragit S100 concentrations of 1%, 5% 
and 10% w/v and magnetic mixing speeds of 500, 1000 and 1500 rpm.    
6.1 Materials  
Liquid Paraffin and Span 85 were supplied by Sigma Aldrich, UK.  Eudragit S100, acetone 
and hexane were supplied by Fisher Scientific, Leicestershire, UK.   
6.2 Methods  
The pectin microspheres were coated using a solvent evaporation technique (Lorenzo et al 
1998).  In this technique, a coating solution is prepared by dissolving Eudragit S100 in 
acetone.  The particles are suspended in the coating solution which is then mixed in liquid 
paraffin.  During the mixing process, the coating solution coats the particles which forms a 
solid Eudragit coating as the acetone evaporates.   
Coating solutions were prepared by dissolving 0.05 g, 0.25 g and 0.5 g of Eudragit in 5 mL of 
acetone on a magnetic mixer at 40 ºC forming coating solutions of 1%, 5% and 10% w/v.  
100 mg of microspheres were dispersed in the coating solution and the dispersion was added 
to an 80 mL beaker with 75 mL of liquid paraffin containing 1.7% Span 85.  The mixture was 
mixed with a 2.5 cm mixing flea at speeds of 500, 1000 and 1500 rpm on a magnetic mixer 
for 3 hours to allow the complete solvent evaporation giving a core to coat ratio that was 
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dependent of the concentration of the coating solution used.  The coated particles were 
collected by suction filtration and washed with three 20 mL portions of hexane and then left 
to dry in an air circulated oven overnight.  Particles were characterised with SEM as 
described in the water in oil emulsion chapter.   
6.3 Results and discussions 
It was hypothesised that the coating solution concentration and mixing speed would affect the 
quality of the coating given to the particles (Figure 6.1).  The uncoated particles are shown in 
Figure 6.2.  
 
Coating solution concentration (w/v) 
 
 1% 5% 10%
 
500
M
ixing speed (rpm
) 
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Figure 6.1 – SEM images of the attempt to coat the particles.  Effects of coating solution concentration (1% left, 
5% center, 10% right) and mixing speed (500 rpm top, 1000 rpm middle, 1500 rpm bottom) can be seen.     
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Figure 6.2 – SEM of the uncoated particles  
6.3.1 Effect of mixing speed on Eudragit S100 coating
Mixing speeds of 500, 1000 and 1500 rpm were investigated in an attempt to coat the 
particles.   Mixing speeds of 500 rpm produced what appeared to be a “ball” of Eudragit. It is 
believed that the particles were not been sufficiently mixed throughout the liquid paraffin 
since it was observed that the majority of the population of particles trailed along the base of 
the beaker during the mixing process.    As this mixing speed was increased to 1000 and 
again to 1500 rpm, the particles were being mixed sufficiently throughout the liquid paraffin 
where it was believed that the particles gained some degree of coating judging by the size 
increase from approximately 10 microns in the uncoated particles to approximately 50 
microns in the coated particles (Figure 6.3).
Figure 6.3 – SEM of what is believed to be coated pectin particles.   
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Paharia et al (2007) and Lorenzo et al (1998) have successfully coated pectin particles by 
solvent dehydration method at mixing speeds of 1000 rpm on a propeller mixer producing 
coated particles with spherical geometries approximately 100 microns in diameter; however it 
is believed other mixing speeds have not been discussed in the literature.   
Paharia et al (2007) and Lorenzo et al (1998) both used a propeller mixer to coat their 
particles and judging from the better agitation the over head mixer gave opposed to the 
magnetic mixer during the production of the pectin particles discussed in chapter 3, it is 
believed that the higher agitation levels would allow the solvent dehydration to occur at a 
better rate yielding individually coated particles. 
6.3.2 Effect of coating solution concentration  
The coating solution concentration affects the core to coat ratio that is give to the particles.  
10% w/v was originally used as investigated Paharia et al (2007) and Lorenzo et al (1998) 
however this led to large Eudragit masses being produced where the particles were believed 
to be stuck inside.  Had the particles been produced with overhead mixing, it may have been 
possible that this concentration would have given a better coating quality since both authors 
using propeller mixers for their studies.   
The coating solution was reduced to 5% w/v.  Towards the end of the mixing process, small 
white spherical beads could be seen though the liquid paraffin which were believed to be 
spheres with some coating.  Due to the decrease in the coating solution concentration, it is 
believed that this allowed the Eudragit to solidify at a faster rate during the solvent 
evaporation process yielding particles with some degree of coating as shown in the SEM 
images (Figure 6.3).  Also the size of the particles produced in this study with 5% w/v 
solutions were smaller (50 microns) than particles that produced by Paharia et al (2007) with 
81 
 
10% w/v solutions (100 microns) showing that the reduction in coating solution concentration 
could be affecting the core: coat ratio.   
6.4 Conclusion 
In this chapter, initial coating studies were carried out in an attempt to coat the particles.  
From the results it was seen that the quality of coating given to the particles could be affected 
by the processing conditions.  From the products that were produced, it was believed in order 
to produce high quality coats, a sufficient level of agitation may be required to allow the 
successful solvent dehydration during the coating procedure.  Also it is believed that choice 
of polymer solution concentration could possibly affect the core: coat ratio where the higher 
concentrations would give thicker coats.  Further investigation into coating is suggested as 
part of future work.   
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Chapter 7 
Final conclusions and future work 
7.0 Final conclusions 
This project looked into the development of calcium pectinate particles for colonic delivery 
via the oral route.  Two particle production methods were investigated, the syringe droplet 
method and the water in oil emulsion method.  In the syringe droplet method, the effects of 
calcium chloride concentration, pectin concentration and magnetic mixing speed were 
investigated.  From the investigated parameters it was seen that mixing speeds of 500 rpm 
and pectin concentrations of 5% w/v were needed to produce spherical particles and the 
increase in calcium chloride concentration decreased the pectin’s permeability.  The 
parameters investigated in the water in oil emulsion method were surfactant concentration, 
magnetic and overhead mixing speed and calcium chloride concentration.  From the results it 
was found that surfactant concentrations of 5% w/v and overhead mixing speeds of 1500 rpm 
were needed in order to produce particles with high orders of sphericity and the increase in 
calcium chloride concentration reduced the particles ability to swell.  Also the higher degree 
of mixing produced with the overhead stirrer also helped in producing spherical particles.  
5-ASA was loaded into the particles produced with the water in oil emulsion method.  Due to 
the drug’s solubility, the drug was not successfully encapsulated in solution; therefore 
loading through suspension was investigated.  Various suspension concentrations were 
investigated along with the effects of calcium chloride concentration on drug loading.  From 
the results it was seen that drug loading decreased with increasing calcium chloride 
concentrations however the loaded drug caused the particles to form irregular structures.    
The particles loaded with 5-ASA suspension were subject to in vitro studies simulating the 
stomach, small intestine and colon.   The effects of calcium chloride concentration on drug 
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release rate were investigated.  The release profiles indicated that the drugs were rapidly 
released in all simulations.  This was believed to be due to the incompatibility between 
micron sized particles and large 5-ASA crystals, causing the crystals to rapidly drop out into 
the release media during the swelling process.  It is believed that the bigger particles 
produced with the syringe droplet method may have been better suited for the encapsulation 
of 5-ASA and controlled release.   
Some initial coating studies for the particles were attempted looking into processing 
conditions of mixing speed and coating solution concentration.  It was observed that the 
addition of an effective coating could be down to using sufficient agitation to allow the 
effective solvent evaporation, to produce the solid coats.  Also, the increase in coating 
solution concentration could affect the core: coat ratio.   
7.1 Future work 
A number of studies could be preformed to tie up the final conclusions.  Firstly, the 5-ASA 
could be re-entrapped (both in solution and suspension) into the calcium pectinate particles 
produced by the syringe droplet method.  Also various drugs with different physiochemical 
characteristics could be entrapped using the water in oil emulsion method to see whether or 
not the 5-ASA is just not compatible with the micron sized calcium pectinate microparticles 
produced using the emulsion method.  Once entrapped, these new particles would then 
undergo the in vitro testing.   
The particles then could undergo further coating studies in which the use of the overhead 
mixer at various speeds (500 – 2000 rpm) would be investigated, to see if better agitation 
would give an improved solvent dehydration during the coating process.   Various coating 
solution concentrations (1% - 10% w/v) and possibly various surfactant concentrations could 
also be explored. 
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Siepmann et al (2007) have discussed the use of various polymer blends that can be used to 
coat particles that have changed the release rate and mechanisms of the delivery vehicle.  
Using polymer blends can be an alternative to adding plasticizers and can overcome sticky 
and brittle coats from being formed.  Ideally two polymers with different physicochemical 
characteristics in the right blend can dramatically alter the delivery system. For example, 
blends of Eudragit S100 and Eudragit L100 have been blended in various ratios showing 
different release patterns.    The use of polymer blends can also prevent the coat from 
ruptuing by using polymers with more flexability where Eudragit NE, a flexible pH 
repsonsive polymer, can prevent brittle coatings from rupturing.  Some polymers are also 
known to prevent degradation in long periods of storage.   
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